Also trades as: 1466.HK (HKSE) · $vol 0M
MNNGF OTC
Baijin Life Science Holdings Limited
1W: +0.0%
1M: +50.0%
3M: +100.0%
YTD: +150.0%
1Y: +87.5%
3Y: +150.0%
5Y: +1150.0%
$0.15
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$89M
-34.2% ▼
5Y CAGR: +15.6%
Gross Profit
$7M
-84.1% ▼
Operating Income
-$48M
-2303.4% ▼
Net Income
-$38M
-11877.0% ▼
EPS (Diluted)
$-0.04
-8840.0% ▼
EBITDA
-$38M
-712.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $63M | $87M | $54M | $136M | $89M |
| YoY Growth | +44.6% | +38.7% | -38.2% | +152.5% | -34.2% |
| Cost of Revenue | $52M | $79M | $36M | $94M | $83M |
| Gross Profit | $11M | $8M | $18M | $42M | $7M |
| Gross Margin | 17.5% | 9.0% | 33.7% | 31.0% | 7.5% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $16M | $17M | $29M | $37M | $57M |
| Operating Expenses | $21M | -$2M | $28M | $44M | $55M |
| Operating Income | -$11M | $10M | -$10M | -$2M | -$48M |
| Operating Margin | -17.7% | 11.0% | -17.8% | -1.5% | -53.8% |
| Interest Expense | $4M | $1M | $276K | $966K | $808K |
| Income Before Tax | -$15M | $9M | -$9M | -$1M | -$43M |
| Tax Expense | $0 | $0 | $16K | -$1M | -$437K |
| Net Income | -$15M | $9M | -$7M | -$316K | -$38M |
| Net Margin | -24.7% | 10.0% | -13.9% | -0.2% | -42.4% |
| EPS (Diluted) | $-0.04 | $0.01 | $-0.01 | $-0.00 | $-0.04 |
| EBITDA | -$10M | $11M | -$6M | $6M | -$38M |
| Shares Outstanding | 373M | 603M | 645M | 694M | 906M |